Stock listing
NYSE:MKG Mallinckrodt Inc Stock
Follow Mallinckrodt Inc into a list and get an email when it puts out news.
Delisted NYSE:MKG no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NYSE:MKG
- Asset type
- Stock
- Exchange
- NYSE
- Currency
- USD
Mallinckrodt Inc on 6ix
- Decks
- 16 decks · latest Nov 10, 2025
Where Mallinckrodt Inc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE:MKG · This page · Delisted | NYSE | United States | USD |
| NYSE American:MNK · Delisted | NYSE American | United States | USD |
| OTC:MNKTQ · Delisted | OTC | United States | USD |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2025 Earnings Presentation | Earnings | 17 slides | Nov 10, 2025 |
| Debt Investor Presentation (October 2025) | Debt investors | 25 slides | Oct 6, 2025 |
| Merger or Acquisition (August 2025) | Merger or acquisition | 87 slides | Aug 1, 2025 |
| Debt Investor Presentation (August 2025) | Debt investors | 57 slides | Aug 1, 2025 |
| Merger or Acquisition (March 2025) | Merger or acquisition | 15 slides | Mar 13, 2025 |
| Merger or Acquisition (March 2025) | Merger or acquisition | 16 slides | Mar 13, 2025 |
| Debt Investor Presentation (August 2023) | Debt investors | 14 slides | Aug 23, 2023 |
| 43rd Annual TD Cowen Health Care Conference (March 2023) | Conference | 13 slides | Mar 7, 2023 |
| Debt Investor Presentation (April 2022) | Debt investors | 46 slides | Apr 14, 2022 |
| Corporate Update (March 2021) | Corporate update | 20 slides | Mar 10, 2021 |
All 16 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Presentation (October 2020) | 43 slides | Oct 13, 2020 | |
| Merger or Acquisition (December 2018) | Merger or acquisition | 15 slides | Dec 6, 2018 |
| Merger or Acquisition (December 2017) | Merger or acquisition | 18 slides | Dec 26, 2017 |
| Merger or Acquisition (August 2015) | Merger or acquisition | 11 slides | Aug 11, 2015 |
| Merger or Acquisition (March 2015) | Merger or acquisition | 8 slides | Mar 5, 2015 |
| Merger or Acquisition (February 2014) | Merger or acquisition | 12 slides | Feb 11, 2014 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| James R Sulat Other companies: Exicure, Inc. (Director · Jan 2, 2021 – Jun 13, 2022 · Past); Arch Therapeutics Inc (Director · Aug 19, 2015 – Sep 27, 2021 · Past); AMAG Pharmaceuticals Inc (Director · Apr 14, 2014 – Nov 16, 2020 · Past); Codexis, Inc. (Director · Apr 21, 2010 – Apr 27, 2010 · Past); Momenta Pharmaceuticals Inc (Director · Jun 5, 2008 – Jun 19, 2019 · Past); Memory Pharmaceuticals Corp (Director · Jun 5, 2006 – Jan 1, 2009 · Past); Maxygen Inc (Former CEO & CFO, Director · May 30, 2006 – Jun 30, 2013 · Past) | Director · Jun 16, 2022 – Nov 14, 2023 · Past |
| Angus C. Russell Other companies: Structure Therapeutics, Inc. (Director · Since at least Aug 26, 2024); Lineage Cell Therapeutics, Inc. (Director · Since at least Dec 12, 2014); TherapeuticsMD, Inc. (Director · Mar 18, 2015 – Sep 29, 2022 · Past); Revance Therapeutics, Inc. (Director · Mar 4, 2014 – Feb 4, 2025 · Past); Questcor Pharmaceuticals Inc (Director · Jun 8, 2013 – Aug 14, 2014 · Past); InterMune Inc (Director · Oct 31, 2011 – Sep 29, 2014 · Past) | Director · Aug 14, 2014 – Jun 16, 2022 · Past |
| Paul M. Bisaro Other companies: Myriad Genetics, Inc. (Director · Since at least Oct 31, 2022); Zoetis Inc. (Chairman of the Board · Since at least May 1, 2015); TherapeuticsMD, Inc. (Director · Mar 20, 2020 – Sep 29, 2022 · Past); Amneal Pharmaceuticals, Inc. (Executive Chairman, Director · May 4, 2018 – May 7, 2019 · Past); Impax Laboratories Inc (President and CEO, Director · Mar 27, 2017 – May 4, 2018 · Past); Zimmer Biomet Holdings, Inc. (Director · Dec 12, 2013 – Mar 31, 2017 · Past) | Director · Since at least Jun 16, 2022 |
| Katina Dorton Other companies: Prelude Therapeutics Incorporated (Director · Since at least Oct 17, 2025); TScan Therapeutics, Inc. (Director · Since at least Jul 15, 2021); Fulcrum Therapeutics, Inc. (Board Member · Since at least Jun 9, 2021); US Ecology Inc (Director · May 26, 2021 – May 2, 2022 · Past); Pandion Therapeutics Inc (Director · Dec 2, 2020 – Apr 1, 2021 · Past) | Director · Since at least Feb 2, 2024 |
| Bryan M Reasons Other companies: Amneal Pharmaceuticals, Inc. (CFO · May 4, 2018 – Aug 21, 2018 · Past); Aclaris Therapeutics, Inc. (Director · Apr 20, 2018 – Jun 1, 2024 · Past); Recro Pharma Inc (Director · Mar 3, 2017 – Apr 8, 2024 · Past); Impax Laboratories Inc (Chief Financial Officer · Apr 13, 2013 – May 4, 2018 · Past) | EVP & CFO · Since at least Mar 18, 2019 |
| Carlos Paya Other companies: Collegium Pharmaceutical, Inc. (Director · Since at least May 15, 2025); Vaxcyte, Inc. (President, Immune Design Corp Chairman, Vaxcyte · Since at least Oct 27, 2021); Standard BioTools Inc. (Director · Mar 23, 2017 – Jun 14, 2023 · Past); Immune Design Corp (President and CEO, Director · Oct 30, 2015 – Apr 2, 2019 · Past) | Director · May 22, 2019 – Jun 16, 2022 · Past |
| Karen Ling Other companies: Bausch + Lomb Corporation (Director · Since at least Feb 27, 2024); iRhythm Holdings, Inc. (Director · Since at least Nov 1, 2021); TherapeuticsMD, Inc. (Director · Apr 16, 2020 – Sep 29, 2022 · Past); American International Group, Inc. New (EVP and Chief HR Officer · Jul 29, 2019 – Mar 30, 2021 · Past) | Director · Aug 12, 2022 – Nov 14, 2023 · Past |
| Daniel Tassé Other companies: DBV Technologies SA (Chief Executive Officer · Since at least Jan 1, 2021); Regenxbio Inc. (Independent Board Member · Since at least Aug 15, 2016); Bellerophon Therapeutics Inc (Director · Feb 13, 2015 – Jun 21, 2018 · Past) | Interim Pres-Hospital Business · May 1, 2015 – May 1, 2015 · Past |
| Diane H Gulyas Other companies: Ingevity Corporation (Director · Since at least Feb 22, 2019); Expeditors International of Washington, Inc. (Director · Since at least May 20, 2016); W. R. Grace & Co (Director · May 5, 2016 – Sep 22, 2021 · Past) | Director · Jul 21, 2016 – Mar 1, 2018 · Past |
| Gary Phillips Other companies: Aldeyra Therapeutics, Inc. (Director · Since at least May 1, 2014); Egalet Corporation (Director · Jun 18, 2019 – May 20, 2020 · Past); Rocket Pharmaceuticals, Inc. (Director · Oct 13, 2015 – Jun 20, 2017 · Past) | Exec. VP & Chief Strategy Ofcr · Oct 21, 2013 – Jan 3, 2018 · Past |
All 47 people
| Person | Seat |
|---|---|
| J Martin Carroll Other companies: Esperion Therapeutics, Inc. (Director · Since at least Jun 1, 2022); TherapeuticsMD, Inc. (Director · Jul 1, 2021 – Aug 10, 2021 · Past); Catalent Inc (Director · Oct 29, 2020 – Dec 18, 2024 · Past) | Director · Mar 12, 2021 – Jun 16, 2022 · Past |
| Michael-Bryant Hicks Other companies: Apria Inc (See Remarks · Mar 15, 2021 – Mar 29, 2022 · Past); Elanco Animal Health Incorporated (See Remarks · Sep 19, 2018 – Mar 1, 2021 · Past); ModivCare Inc (SVP, General Counsel & Sec · Jan 6, 2014 – Feb 25, 2016 · Past) | General Counsel · Mar 7, 2016 – Jan 3, 2018 · Past |
| Paul Carter Other companies: Immatics N.V. (Non-Executive Director · Since at least Mar 18, 2026); Alder BioPharmaceuticals Inc (Director · Sep 28, 2015 – Oct 22, 2019 · Past); Gilead Sciences, Inc. (EVP Commercial Ops · Jul 1, 2015 – Aug 1, 2016 · Past) | Director · May 16, 2018 – Jun 16, 2022 · Past |
| Joann A Reed Other companies: American Tower Corporation (REIT) (Director · Mar 10, 2017 – Mar 10, 2025 · Past); Waters Corporation (Director · Jan 4, 2016 – Mar 5, 2021 · Past) | Director · Jul 21, 2016 – Jun 16, 2022 · Past |
| Joseph A Zaccagnino Other companies: Newalliance Bancshares Inc (Director · May 28, 2010 – Apr 15, 2011 · Past); Covidien plc (Director · Jun 29, 2007 – Jan 26, 2015 · Past) | Director · Jun 28, 2013 – May 15, 2019 · Past |
| Matthew K Harbaugh Other companies: Qnity Electronics, Inc. (Chief Financial Officer · Since at least Sep 30, 2025); NuVasive Inc (EVP and CFO · Jan 1, 2020 – Sep 1, 2023 · Past) | EVP & President, Spec Gen · Jan 2, 2018 – Apr 2, 2019 · Past |
| Steven J Romano Other companies: Silence Therapeutics PLC (EVP and Chief R&D Officer · Since at least Jan 2, 2025); Dianthus Therapeutics, Inc. (Director · Since at least Sep 16, 2024) | EVP & Chief Sci. Ofcr · Jun 16, 2022 – Jun 16, 2022 · Past |
| Abbas Hussain Other companies: Moderna, Inc. (Director · Since at least Oct 2, 2024) | Director · Since at least Feb 2, 2024 |
| David R Carlucci Other companies: Mastercard Incorporated (Director · Jun 11, 2019 – Jun 25, 2019 · Past) | Director · May 15, 2019 – Jun 16, 2022 · Past |
| George Kegler Other companies: Enveric Biosciences, Inc. (Director, Chair of the Audit Committee · Since at least Dec 30, 2020) | EVP & CFO, Interim · Dec 6, 2018 – Jan 9, 2019 · Past |
| Leslie Donato Other companies: Cencora, Inc. (Director · Aug 8, 2019 – Nov 5, 2026 · Past) | Director · Since at least Jul 31, 2025 |
| Mark Trudeau Other companies: TE Connectivity plc (Board Member · Since at least Nov 9, 2020) | President and CEO, Director · Nov 12, 2020 – Jun 16, 2022 · Past |
| Riad Hussein El-Dada Other companies: Greenland Mines Ltd (Director · Since at least Aug 7, 2025) | Director · Jun 16, 2022 – Nov 14, 2023 · Past |
| Ronald K Lloyd Other companies: Elutia, Inc. (PRESIDENT AND CEO, Director · Oct 7, 2020 – Mar 8, 2022 · Past) | Exec. VP & Pres, Hospital · Jan 4, 2016 – Apr 2, 2018 · Past |
| Sigurdur O Olafsson Other companies: Pfenex Inc (Director · May 5, 2017 – May 9, 2019 · Past) | President and CEO, Director · Since at least Jun 23, 2022 |
| Susan Michele Silbermann Other companies: Hillevax Inc (Director · Apr 28, 2022 – Aug 19, 2022 · Past) | Director · Oct 5, 2022 – Nov 14, 2023 · Past |
| Woodrow A Myers Jr Other companies: Personalis, Inc. (Director · Since at least Mar 6, 2021) | Director · Jun 16, 2022 – Nov 14, 2023 · Past |
| Daniel Arthur Celentano | Director · Jun 16, 2022 – Nov 14, 2023 · Past |
| David Keenan | Director · Jun 13, 2013 – Jun 13, 2013 · Past |
| Frank B Raciti | Controller & CAO · Since at least Aug 19, 2025 |
| Frank Scholz | EVP & Chf Ops & Dig Innov Off · Mar 17, 2014 – Apr 1, 2019 · Past |
| Henriette Nielsen | EVP & Chief Transformation OFC · Since at least Aug 17, 2022 |
| Hugh M O'Neill | See Remarks · May 10, 2016 – Jun 16, 2022 · Past |
| Hugh Paul ONeill | EVP, Chief Operations Officer · Since at least Feb 28, 2024 |
| Ian J Watkins | See Remarks · Nov 11, 2020 – Jun 16, 2022 · Past |
| Kassie Harrold | EVP & Chief Compliance Officer · Feb 25, 2021 – Jan 1, 2025 · Past |
| Kathy A Schaefer | Sr. VP Fin & Corp. Controller · Jun 28, 2013 – Apr 1, 2021 · Past |
| Lisa French | EVP & Chief Commercial Officer · Since at least Oct 1, 2022 |
| Mario D Saltarelli | Sr. VP & Chief Science Ofcr. · Oct 21, 2013 – May 18, 2015 · Past |
| Mark Anthony Tyndall | EVP & CLO and Corp Sec · Since at least Aug 17, 2022 |
| Mark T Bradley | EVP, Chief Integration Officer · Since at least Jul 31, 2025 |
| Paul Efron | Director · Since at least Jul 31, 2025 |
| Scott Hirsch | Director · Since at least Jul 31, 2025 |
| Stefano R Carchedi | See Remarks · Jun 28, 2013 – Jun 28, 2013 · Past |
| Stephen Andrew Welch | EVP & Head of Spec Generics · Since at least Aug 17, 2022 |
| Tracy Basso | EVP & CHRO · Since at least Jul 31, 2025 |
| Wesley Wheeler | Director · Since at least Jul 31, 2025 |
Log in to ask 6ix AI your own questions about Mallinckrodt Inc.